bf/NASDAQ:DSP_icon.jpeg

COM:VIANTINC

Viant

  • Stock

USD

Last Close

19.02

22/11 21:00

Market Cap

643.20M

Beta: -

Volume Today

247.76K

Avg: -

Company Overview

Metric
Company NameViant Technology Inc.Apollo Endosurgery
SymbolDSP
MSH IDCOM:VIANTINCCOM:APOLLOENDO
MarketSTOCKSPRIVATE
SectorTechnologyHealthcare & Health Services
IndustrySoftware - ApplicationMedical Devices
CountryUSUS
StagePost-IPO Debt
Employee Count334
Websiteviantinc.comapolloendo.com
LinkedIn
Founders

Market Metrics

Metric
Market Cap643.20M
Enterprise Value
Monthly Web Traffic4.86K
Web Traffic Growth0.32
Valuation
Raised Capital35M

Financial Performance

Metric
Revenue222.93M
Revenue (LTM)
Revenue (NTM)
Gross Profit102.45M
EBITDA-3.56M
Operating Income-18.30M
Net Income-3.44M
EPS-0.23
Diluted EPS-0.23
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.47
Operating Profit Margin-0.03
EBITDA Margin-0.02
Net Profit Margin0.00
Return on Equity0.01
Return on Assets0.00
Return on Capital Employed-0.03

Valuation Multiples

Metric
P/E Ratio-4.09
P/B Ratio2.10
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio3.28
EV Multiple586.85

Operational Metrics

Metric
Days Sales Outstanding181.68
Days Payables Outstanding96.15
Days Inventory Outstanding
Operating Cycle192.33
Cash Conversion Cycle48.91
Asset Turnover0.60

Cash Flow Metrics

Metric
Operating Cash Flow37.75M
Free Cash Flow24.28M
Cash Flow to Debt1.70
Operating Cash Flow/Sales0.19
Free Cash Flow Yield0.02

Balance Sheet Metrics

Metric
Cash & Equivalents216.46M
Accounts Receivable-16.12M
Inventory
Goodwill12.42M
Debt to Capitalization0.30
Debt to Assets0.07
Current Ratio3.60
Quick Ratio3.24

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.15
R&D to Revenue0.11
SG&A to Revenue0.20